Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Toshikazu HADA"'
Autor:
T. Yamamoto, Hideji Nakamura, Hiroko Iijima, Yoshinori Iwata, Toshikazu Hada, Soji Shimomura, Shuhei Nishiguchi, Masaki Saito, Weidong Liu, Shohei Yoshikawa, Hiroyasu Imanishi, Hirayuki Enomoto, Noritoshi Koh, Ke Cao
Publikováno v:
Journal of Gastroenterology. 44:228-235
Vitamin K(2) has been reported to suppress the growth of human hepatocellular carcinoma (HCC) in vitro and hepatocarcinogenesis in hepatitis C virus (HCV)-related cirrhosis in vivo. Hepatoma-derived growth factor (HDGF) is a unique nuclear targeting
Autor:
Takeshi Saito, Hideo Kawarasaki, Masami Ohmori, Weidong Liu, Toshikazu Hada, Koichi Mizuta, Koichi Sakamoto, T. Fujiwara, Yoshikazu Yasuda, Yukihiro Sanada, Shuhei Nishiguchi, Youichi Kawano, Satoshi Egami, Yuka Takatsuka, Shuji Hisikawa
Publikováno v:
Pediatric Transplantation. 11:694-697
Hypocholinesterasemia is often observed clinically, especially in various liver diseases. Not well known, however, is the fact that some patients have a hereditary BChE variant. Little has been reported on liver transplants associated with this hered
Autor:
Toshikazu Hada, Naoto Ikeda, Shuhei Nishiguchi, Soji Shimomura, Weidong Liu, Masaki Saito, Tetsuo Yamamoto, T. Yamamoto, Masao Ohno, Hideji Nakamura, Toshiyuki Sakai, Naoki Hara, Hiroyasu Imanishi
Publikováno v:
Hepatology Research. 37:360-365
Aim: Vitamin K2 has been reported to inhibit the growth of human hepatocellular carcinoma (HCC) in vitro and suppress hepatocarcinogenesis in vivo. However, its inhibitory mechanism has not yet been clarified. Methods: Different concentrations of vit
Autor:
Eijiro Hayashi, Hirayuki Enomoto, Hiroyuki Ogawa, Toshikazu Hada, Hirokazu Uyama, Norio Hayashi, Yorihide Okuda, Kenya Yoshida, Mitsunari Yamamoto, Hideji Nakamura
Publikováno v:
Hepatology Research. 37:325-330
Aims: We previously reported the potential effect of combination therapy of an initial high-dose interferon (IFN) and amantadine on the eradication of HCV-RNA in patients with chronic hepatitis C. The additive effects of amantadine on interferon and
Autor:
Toshikazu Hada, Jidong Cheng
Publikováno v:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents. 4:199-206
Autor:
Naoto Ikeda, Tetsuo Yamamoto, Toshikazu Hada, S. Shimomura, Naoki Hara, Hiroyasu Imanishi, Masao Ohno, Weidong Liu, Yuna Iwamoto, Masaki Saito, Hideji Nakamura
Publikováno v:
Internal Medicine. 44:285-289
The HFE, H ferritin, TFR2, and ferroportin 1 genes of a Japanese patient diagnosed as having hemochromatosis were amplified by PCR and sequenced. A novel mutation in the ferroportin 1 was found in the patient. It was located in the noncoding region o
Autor:
Haruki Okamura, Hisayuki Itoi, Nobuyuki Terada, Hiroko Tsutsui, Toshikazu Hada, Yoshihiro Fujimori, Eizo Kakishita, Kenji Nakanishi, Ayako Sugihara, Kiyoshi Matsui, Hiroshi Hara
Publikováno v:
Transplantation. 78:1245-1250
BACKGROUND Interleukin (IL)-18 stimulates T helper 1 (Th1)-mediated immune responses and the development of cytotoxic T lymphocytes (CTLs). Antihost CTLs are major effectors in acute graft-versus-host disease (aGvHD), a potentially fatal complication
Publikováno v:
International Immunology. 16:1733-1739
Although IL-18 was initially regarded as a factor that enhances IFN-gamma production from Th1 cells, later studies revealed its potential to induce Th2 cytokine production from T cells, NK cells and basophils/mast cells. Very recently, we demonstrate
Autor:
Hiroyasu Imanishi, Toshikazu Hada, Toshihiro Sugiyama, Hideji Nakamura, Takayuki Morisaki, Jidong Cheng, Weidong Liu
Publikováno v:
Biochemical and Biophysical Research Communications. 322:458-464
There is growing evidence to show that hepatic oval cells contribute to liver regeneration, dysplastic nodule formation, and hepato-carcinogenesis. Peroxisome proliferator-activated receptors (PPARs) and their ligands play an important role in cell g
Autor:
Hideji Nakamura, Weidong Liu, Takayuki Morisaki, Toshikazu Hada, Jidong Cheng, Hiroyasu Imanishi, Kazuya Higashino
Publikováno v:
Cancer Science. 95:666-673
Recent studies have shown that selective cyclooxygenase-2 (COX-2) inhibitors induce growth inhibition and cell cycle arrest in hepatocellular carcinoma (HCC) cell lines. However, the mechanism by which COX-2 inhibitors regulate the cell cycle and whe